Rating Change
BMO Capital reiterated its Outperform rating on HealthEquity, Inc. (NASDAQ:HQY) on October 21, 2026.
reiterateNASDAQ:HQY
BMO Capital Reiterates Outperform Rating on HealthEquity, Inc. (HQY)
BMO Capital reiterated its Outperform rating on HealthEquity, Inc. (NASDAQ:HQY) on October 21, 2026.
At publication ·
What changed
HealthEquity, Inc. (NASDAQ:HQY) · reiterate
- Firm
- BMO Capital
- Rating
- Outperform to Outperform
- Price at event
- $97.88
- Market capitalization
- $8.4B
At a glance
Key takeaways
- BMO Capital maintained an Outperform rating on HealthEquity (HQY) on October 21, 2026, while the stock trades at $97.88 with an $8.4B market capitalization.
- All 10 of the most recent analyst ratings are Buy or Outperform with no Sell ratings, indicating consensus bullish sentiment.
- HealthEquity stock gained only 0.6% over the past 52 weeks despite widespread positive analyst coverage.
- Analyst ratings are one input among many for investment decisions and have mixed predictive power on their own.
Market Context
HealthEquity, Inc. operates in the Healthcare sector. The stock currently trades at $97.88 with a market capitalization of $8.4B. The stock has gained 0.6% over the past 52 weeks.
Analyst coverage from BMO Capital provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for HealthEquity, Inc.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for HealthEquity, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Oct 21, 2026 | BMO Capital | Outperform | N/A |
| Sep 18, 2026 | Barclays | Overweight | N/A |
| Aug 31, 2026 | Deutsche Bank | Buy | N/A |
| Aug 28, 2026 | BTIG | Buy | N/A |
| Jul 24, 2026 | BTIG | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View HQY Stock Page
Frequently Asked Questions
What does the Outperform rating mean for HQY?
A rating of Outperform from BMO Capital reflects the analyst's outlook on HealthEquity, Inc. (NASDAQ:HQY). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the HQY forecast page.
Loading related coverage…